Impact of contrast enhanced MRI on lymphocyte DNA damage and serum visfatin level

Yildiz S., Cece H., Kaya I., Celik H., Taskin A., Aksoy N., et al.

CLINICAL BIOCHEMISTRY, cilt.44, ss.975-979, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Objectives: Nephrogenic systemic fibrosis is a novel clinical entity encountered in subjects undergoing contrast enhanced magnetic resonance imaging (MRI). The aim of the present study is to evaluate the impact of contrast enhanced MRI exposure on lymphocyte DNA damage and serum levels of visfatin.